Table of Contents 1 Nanoparticles in Biotechnology and Pharmaceuticals Market Overview 1.1 Nanoparticles in Biotechnology and Pharmaceuticals Product Overview 1.2 Nanoparticles in Biotechnology and Pharmaceuticals Market Segment by Type 1.2.1 Fullerenes 1.2.2 Liquid Crystals 1.2.3 Liposomes 1.2.4 Nanoshells 1.2.5 Quantum dots 1.2.6 Superparamagnetic nanoparticles 1.3 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Size by Type 1.3.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth by Type 1.3.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Type (2014-2019) 1.3.3 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Market Share by Type (2014-2019) 1.3.4 Global Nanoparticles in Biotechnology and Pharmaceuticals Price by Type (2014-2019) 2 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Competition by Company 2.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Company (2014-2019) 2.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Share by Company (2014-2019) 2.3 Global Nanoparticles in Biotechnology and Pharmaceuticals Price by Company (2014-2019) 2.4 Global Top Players Nanoparticles in Biotechnology and Pharmaceuticals Manufacturing Base Distribution, Sales Area, Product Types 2.5 Nanoparticles in Biotechnology and Pharmaceuticals Market Competitive Situation and Trends 2.5.1 Nanoparticles in Biotechnology and Pharmaceuticals Market Concentration Rate 2.5.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Share of Top 5 and Top 10 Players 2.5.3 Mergers & Acquisitions, Expansion 3 Nanoparticles in Biotechnology and Pharmaceuticals Company Profiles and Sales Data 3.1 Roche 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification 3.1.3 Roche Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin(2014-2019) 3.1.4 Main Business Overview 3.2 GE Healthcare 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification 3.2.3 GE Healthcare Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin(2014-2019) 3.2.4 Main Business Overview 3.3 Merck 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification 3.3.3 Merck Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin(2014-2019) 3.3.4 Main Business Overview 3.4 Novartis 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification 3.4.3 Novartis Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin(2014-2019) 3.4.4 Main Business Overview 3.5 AMAG Pharmaceuticals 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification 3.5.3 AMAG Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin(2014-2019) 3.5.4 Main Business Overview 3.6 Amgen 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification 3.6.3 Amgen Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin(2014-2019) 3.6.4 Main Business Overview 3.7 Bausch & Lomb 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification 3.7.3 Bausch & Lomb Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin(2014-2019) 3.7.4 Main Business Overview 3.8 Biogen 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification 3.8.3 Biogen Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin(2014-2019) 3.8.4 Main Business Overview 3.9 Celgene 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification 3.9.3 Celgene Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin(2014-2019) 3.9.4 Main Business Overview 3.10 Gilead 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification 3.10.3 Gilead Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin(2014-2019) 3.10.4 Main Business Overview 3.11 Ipsen 3.12 Leadiant Biosciences 3.13 nanoComposix 3.14 Pacira Pharmaceuticals 3.15 Pfizer 3.16 Shire 4 Nanoparticles in Biotechnology and Pharmaceuticals Market Status and Outlook by Regions 4.1 Global Market Status and Outlook by Regions 4.1.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Size and CAGR by Regions 4.1.2 North America 4.1.3 Asia-Pacific 4.1.4 Europe 4.1.5 South America 4.1.6 Middle East and Africa 4.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Revenue by Regions 4.2.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Regions (2014-2019) 4.2.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Market Share by Regions (2014-2019) 4.2.3 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin (2014-2019) 4.3 North America Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin 4.3.1 United States 4.3.2 Canada 4.3.3 Mexico 4.4 Europe Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin 4.4.1 Germany 4.4.2 UK 4.4.3 France 4.4.4 Italy 4.4.5 Russia 4.4.6 Turkey 4.5 Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin 4.5.1 China 4.5.2 Japan 4.5.3 Korea 4.5.4 Southeast Asia 4.5.4.1 Indonesia 4.5.4.2 Thailand 4.5.4.3 Malaysia 4.5.4.4 Philippines 4.5.4.5 Vietnam 4.5.5 India 4.5.6 Australia 4.6 South America Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin 4.6.1 Brazil 4.7 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin 4.7.1 Egypt 4.7.2 GCC Countries 5 Nanoparticles in Biotechnology and Pharmaceuticals Application/End Users 5.1 Nanoparticles in Biotechnology and Pharmaceuticals Segment by Application 5.1.1 Biotechnology 5.1.2 Pharmaceutical 5.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Product Segment by Application 5.2.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales by Application 5.2.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Application (2014-2019) 6 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast 6.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue Forecast (2019-2025) 6.1.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate Forecast (2019-2025) 6.1.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate Forecast (2019-2025) 6.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Forecast by Regions 6.2.1 North America Nanoparticles in Biotechnology and Pharmaceuticals Sales and Revenue Forecast (2019-2025) 6.2.2 Europe Nanoparticles in Biotechnology and Pharmaceuticals Sales and Revenue Forecast (2019-2025) 6.2.3 Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales and Revenue Forecast (2019-2025) 6.2.3.1 China 6.2.3.2 Japan 6.2.3.3 Korea 6.2.3.4 Southeast Asia 6.2.3.5 India 6.2.3.6 Australia 6.2.4 South America Nanoparticles in Biotechnology and Pharmaceuticals Sales and Revenue Forecast (2019-2025) 6.2.5 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales and Revenue Forecast (2019-2025) 6.2.5.1 Egypt 6.2.5.2 GCC Countries 6.3 Nanoparticles in Biotechnology and Pharmaceuticals Forecast by Type 6.3.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Revenue Forecast by Type (2019-2025) 6.3.2 Fullerenes Gowth Forecast 6.3.3 Liquid Crystals Gowth Forecast 6.4 Nanoparticles in Biotechnology and Pharmaceuticals Forecast by Application 6.4.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Forecast by Application (2019-2025) 6.4.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Forecast in Biotechnology 6.4.3 Global Nanoparticles in Biotechnology and Pharmaceuticals Forecast in Pharmaceutical 7 Nanoparticles in Biotechnology and Pharmaceuticals Upstream Raw Materials 7.1 Nanoparticles in Biotechnology and Pharmaceuticals Key Raw Materials 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price 7.1.3 Raw Materials Key Suppliers 7.2 Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Nanoparticles in Biotechnology and Pharmaceuticals Industrial Chain Analysis 8 Marketing Strategy Analysis, Distributors 8.1 Marketing Channel 8.1.1 Direct Marketing 8.1.2 Indirect Marketing 8.1.3 Marketing Channel Development Trend 8.2 Distributors 8.3 Downstream Customers 9 Research Findings and Conclusion Appendix Methodology/Research Approach Research Programs/Design Market Size Estimation Market Breakdown and Data Triangulation Data Source Secondary Sources Primary Sources Disclaimer

List of Tables and Figures Figure Nanoparticles in Biotechnology and Pharmaceuticals Product Picture Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) Status and Outlook (2014-2025) Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) Status and Outlook (2014-2025) Figure Product Picture of Fullerenes Table Major Players of Fullerenes Figure Global Fullerenes Sales (MT) and Growth Rate (%)(2014-2018) Figure Product Picture of Liquid Crystals Table Major Players of Liquid Crystals Figure Global Liquid Crystals Sales (MT) and Growth Rate (%)(2014-2019) Figure Product Picture of Liposomes Table Major Players of Liposomes Figure Global Liposomes Sales (MT) and Growth Rate (%)(2014-2019) Figure Product Picture of Nanoshells Table Major Players of Nanoshells Figure Global Nanoshells Sales (MT) and Growth Rate (%)(2014-2019) Figure Product Picture of Quantum dots Table Major Players of Quantum dots Figure Global Quantum dots Sales (MT) and Growth Rate (%)(2014-2019) Figure Product Picture of Superparamagnetic nanoparticles Table Major Players of Superparamagnetic nanoparticles Figure Global Superparamagnetic nanoparticles Sales (MT) and Growth Rate (%)(2014-2019) Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Comparison by Type Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) by Type (2014-2019) Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Share (%) by Type (2014-2019) Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share (%) by Type (2014-2019) Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share (%) by Type in 2018 Table Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) by Type (2014-2019) Table Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Share (%) by Type (2014-2019) Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Share (%) by Type (2014-2019) Figure 2018 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share (%) by Type Table Global Nanoparticles in Biotechnology and Pharmaceuticals Price (USD/Kg) by Type (2014-2019) Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) by Company (2014-2019) Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Share (%) by Company (2014-2019) Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Share (%) by Company in 2018 Table Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) by Company (2014-2019) Table Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Share (%) by Company (2014-2019) Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Share (%) by Company in 2018 Table Global Market Nanoparticles in Biotechnology and Pharmaceuticals Average Price (USD/Kg) by Company (2014-2019) Table Global Nanoparticles in Biotechnology and Pharmaceuticals Top Players Manufacturing Base Distribution and Sales Area Table Global Nanoparticles in Biotechnology and Pharmaceuticals Top Players Product Category Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Market Share (%) of Top 5 Players Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Market Share (%) of Top 10 Players Table Roche Basic Information List Table Roche Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification Table Roche Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Roche Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate (2014-2019) Figure Roche Nanoparticles in Biotechnology and Pharmaceuticals Sales Global Market Share (%)(2014-2019) Table GE Healthcare Basic Information List Figure GE Healthcare Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification Table GE Healthcare Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure GE Healthcare Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate (2014-2019) Figure GE Healthcare Nanoparticles in Biotechnology and Pharmaceuticals Sales Global Market Share (%)(2014-2019) Table Merck Basic Information List Figure Merck Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification Table Merck Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Merck Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate (2014-2019) Figure Merck Nanoparticles in Biotechnology and Pharmaceuticals Sales Global Market Share (%)(2014-2019) Table Novartis Basic Information List Figure Novartis Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification Table Novartis Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Novartis Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate (2014-2019) Figure Novartis Nanoparticles in Biotechnology and Pharmaceuticals Sales Global Market Share (%)(2014-2019) Table AMAG Pharmaceuticals Basic Information List Figure AMAG Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification Table AMAG Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure AMAG Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate (2014-2019) Figure AMAG Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Sales Global Market Share (%)(2014-2019) Table Amgen Basic Information List Figure Amgen Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification Table Amgen Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Amgen Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate (2014-2019) Figure Amgen Nanoparticles in Biotechnology and Pharmaceuticals Sales Global Market Share (%)(2014-2019) Table Bausch & Lomb Basic Information List Figure Bausch & Lomb Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification Table Bausch & Lomb Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Bausch & Lomb Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate (2014-2019) Figure Bausch & Lomb Nanoparticles in Biotechnology and Pharmaceuticals Sales Global Market Share (%)(2014-2019) Table Biogen Basic Information List Figure Biogen Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification Table Biogen Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Biogen Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate (2014-2019) Figure Biogen Nanoparticles in Biotechnology and Pharmaceuticals Sales Global Market Share (%)(2014-2019) Table Celgene Basic Information List Figure Celgene Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification Table Celgene Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Celgene Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate (2014-2019) Figure Celgene Nanoparticles in Biotechnology and Pharmaceuticals Sales Global Market Share (%)(2014-2019) Table Gilead Basic Information List Figure Gilead Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification Table Gilead Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Gilead Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate (2014-2019) Figure Gilead Nanoparticles in Biotechnology and Pharmaceuticals Sales Global Market Share (%)(2014-2019) Table Ipsen Basic Information List Table Leadiant Biosciences Basic Information List Table nanoComposix Basic Information List Table Pacira Pharmaceuticals Basic Information List Table Pfizer Basic Information List Table Shire Basic Information List Table Global Nanoparticles in Biotechnology and Pharmaceuticals Market Size Comparison by Regions (2014-2025) Figure North America Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Europe Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure South America Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) and Growth Rate (%)(2014-2025) Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) by Regions (2014-2019) Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share (%) by Regions (2014-2019) Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share (%) by Regions (2014-2019) Figure 2018 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share (%) by Regions Table Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) by Regions (2014-2019) Table Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share (%) by Regions (2014-2019) Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share (%) by Regions (2014-2019) Figure 2018 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share (%) by Regions Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure North America Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate Table North America Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure United States Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure United States Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure Canada Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure Canada Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure Mexico Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure Mexico Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure Europe Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate Table Europe Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Germany Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure Germany Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) (2014-2019) Figure UK Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure UK Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure France Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure France Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure Italy Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure Italy Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure Russia Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure Russia Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure Turkey Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure Turkey Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate Table Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure China Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure China Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure Japan Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure Japan Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure Korea Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure Korea Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure Southeast Asia Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure Southeast Asia Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure Indonesia Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure Indonesia Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure Thailand Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure Thailand Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure Malaysia Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure Malaysia Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure Philippines Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure Philippines Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure Vietnam Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure Vietnam Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure India Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure India Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure Australia Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure Australia Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure South America Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate Table South America Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Brazil Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure Brazil Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate Table Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure North Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure North Africa Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure GCC Countries Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019) Figure GCC Countries Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019) Figure Biotechnology Examples Figure Pharmaceutical Examples Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) Comparison by Application (2014-2025) Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) by Application (2014-2019) Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Share (%) by Application (2014-2019) Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share (%) by Application (2014-2019) Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share (%) by Application in 2018 Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025) Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) Forecast by Regions (2019-2025) Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share (%) Forecast by Regions (2019-2025) Figure North America Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure North America Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025) Figure Europe Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure Europe Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025) Figure China Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure China Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025) Figure Japan Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure Japan Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025) Figure Korea Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure Korea Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025) Figure India Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure India Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025) Figure Australia Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure Australia Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025) Figure South America Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure South America Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025) Figure North Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure North Africa Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025) Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (Million USD) Forecast by Type (2019-2025) Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share (%) Forecast by Type (2019-2025) Table Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) Forecast by Type (2019-2025) Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share (%) Forecast by Type (2019-2025) Figure Fullerenes Sales Growth Forecast Figure Liquid Crystals Sales Growth Forecast Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) Forecast by Application (2019-2025) Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Forecast by Application (2019-2025) Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) Forecast in Biotechnology Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) Forecast in Pharmaceutical Table Key Raw Materials Lists Figure Key Raw Materials Price Table Raw Materials Key Suppliers Lists Figure Nanoparticles in Biotechnology and Pharmaceuticals Manufacturing Cost Structure Figure Nanoparticles in Biotechnology and Pharmaceuticals Industrial Chain Analysis Table Distributors List Table Nanoparticles in Biotechnology and Pharmaceuticals Downstream Customers

Roche GE Healthcare Merck Novartis AMAG Pharmaceuticals Amgen Bausch & Lomb Biogen Celgene Gilead Ipsen Leadiant Biosciences nanoComposix Pacira Pharmaceuticals Pfizer Shire